Department of Pathology and Laboratory Medicine, Baylor Scott and White Central Texas, Temple, Texas, USA.
Transfusion and Apheresis Medicine Services, Department of Pathology, Baystate Medical Center, Baystate Health, Springfield, Massachusetts, USA.
J Clin Apher. 2020 Sep;35(5):460-468. doi: 10.1002/jca.21814. Epub 2020 Aug 17.
The wide spread availability and use of sophisticated high-speed telecommunication networks coupled with inexpensive and easily accessible computing capacity have catalyzed the creation of new tools and strategies for healthcare delivery. Such tools and strategies are of value to apheresis medicine (AM) practitioners if they improve delivery of patient care, enhance safety during a therapeutic apheresis (TA) intervention, facilitate care access, advance technical capabilities of apheresis devices, and/or elevate quality performance within TA programs. In the past several years, healthcare delivery systems' adoption of telecommunication technologies has been fostered by organizational financial and quality improvement objectives. More recently, adoption of telehealth technologies has been catalyzed by the COVID-19 pandemic as these technologies enhance both patient and provider safety in an era of social distancing. These changes will also influence the delivery of TA services which now can be generally viewed in a tripartite model format comprised of traditional hospital-based fixed site locales, mobile TA operations and lately an evolving telemedicine remote management model now reffered to as telapheresis (TLA). This communication developed by the Public Affairs and Advocacy Committee of the American Society for Apheresis (ASFA) and endorsed by its Board of Directors, reviews and describes various aspects of established and evolving electronic technologies related to TLA and the practice of AM. In subsequent companion publications, additional aspects to TLA will be explored and ASFA's vision of reasonable, regulatory compliant and high-quality TLA practices will be expounded.
高速、普及的电信网络的广泛应用,以及廉价、便捷的计算能力,为医疗保健服务的提供创造了新的工具和策略。如果这些工具和策略能够改善患者护理的提供、提高治疗性血液成分去除术 (TA) 干预期间的安全性、促进护理的可及性、提高血液成分去除设备的技术能力,以及/或提升 TA 项目中的质量表现,那么它们对单采医学 (AM) 从业者来说是有价值的。在过去几年中,医疗保健服务系统采用电信技术是由组织的财务和质量改进目标推动的。最近,远程医疗技术的采用受到了 COVID-19 大流行的推动,因为这些技术在保持社交距离的时代提高了患者和提供者的安全性。这些变化也将影响 TA 服务的提供,现在可以普遍以三方模式的格式来看待,包括传统的基于医院的固定场所、移动 TA 操作,以及最近发展起来的远程医疗远程管理模式,现在称为远程单采 (TLA)。本通讯由美国单采协会 (ASFA) 的公共事务和宣传委员会制定,并得到其董事会的认可,审查和描述了与 TLA 和 AM 实践相关的各种已建立和新兴的电子技术方面。在随后的配套出版物中,将探讨 TLA 的其他方面,并阐述 ASFA 对合理、符合监管要求和高质量 TLA 实践的愿景。